Bevacizumab in MBC 1 Breast Cancer Take home message Sabino De Placido.
Biomarkers and Surrogate Endpoints in Drug Development Technical and Regulatory Considerations Biomarkers and Surrogate Endpoints in Drug Development Technical.
SHARE: Metastatic Breast Cancer: Cutting-Edge Research from National Cancer with Dr. Patricia Steeg
Locally advanced and metastatic disease Eribulin mesylate (E7389): review of efficacy and tolerability Jennifer Foglietta Ospedale Santa Maria della Misericordia.
Department of Oncology & Neurosciences Stefano Iacobelli University “G. d’Annunzio” Chieti-Pescara, Italy Consorzio CINBO Medical Management of Breast.
